Anuh Pharma Ltd banner
A

Anuh Pharma Ltd
BSE:506260

Watchlist Manager
Anuh Pharma Ltd
BSE:506260
Watchlist
Price: 82.57 INR 0.55% Market Closed
Market Cap: ₹4.1B

Relative Value

The Relative Value of one ANUHPHR stock under the Base Case scenario is hidden INR. Compared to the current market price of 82.57 INR, Anuh Pharma Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ANUHPHR Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ANUHPHR Competitors Multiples
Anuh Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Anuh Pharma Ltd
BSE:506260
4.1B INR 0.6 10.5 7.2 8.8
US
Eli Lilly and Co
NYSE:LLY
990.8B USD 15.2 48 32.3 34.4
US
Johnson & Johnson
NYSE:JNJ
590.6B USD 6.3 22 15.3 18.8
CH
Roche Holding AG
SIX:ROG
285.8B CHF 4.7 30.6 12.9 15.1
UK
AstraZeneca PLC
LSE:AZN
232.4B GBP 5.4 31.2 17.2 24.2
CH
Novartis AG
SIX:NOVN
238.6B CHF 5.5 22 13.6 17.4
US
Merck & Co Inc
NYSE:MRK
298.8B USD 4.6 16.3 10.2 11.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.6 9.9 11.6
US
Pfizer Inc
NYSE:PFE
157.2B USD 2.5 20.2 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
122.1B USD 2.5 17.3 6.8 8.7
P/E Multiple
Earnings Growth PEG
IN
A
Anuh Pharma Ltd
BSE:506260
Average P/E: 23.2
10.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22
7%
3.1
CH
Roche Holding AG
SIX:ROG
30.6
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.2
26%
1.2
CH
Novartis AG
SIX:NOVN
22
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.3
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
13.6
7%
1.9
US
Pfizer Inc
NYSE:PFE
20.2
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.3
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
A
Anuh Pharma Ltd
BSE:506260
Average EV/EBITDA: 42.4
7.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
32.3
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.3
2%
7.7
CH
Roche Holding AG
SIX:ROG
12.9
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.2
11%
1.6
CH
Novartis AG
SIX:NOVN
13.6
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.2
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
7%
1.4
US
Pfizer Inc
NYSE:PFE
7.5
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.8
-13%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
A
Anuh Pharma Ltd
BSE:506260
Average EV/EBIT: 90.6
8.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.4
17%
2
US
Johnson & Johnson
NYSE:JNJ
18.8
6%
3.1
CH
Roche Holding AG
SIX:ROG
15.1
6%
2.5
UK
AstraZeneca PLC
LSE:AZN
24.2
24%
1
CH
Novartis AG
SIX:NOVN
17.4
12%
1.5
US
Merck & Co Inc
NYSE:MRK
11.9
6%
2
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.6
8%
1.5
US
Pfizer Inc
NYSE:PFE
10
-1%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.7
-6%
N/A